Miljenko Valentin Panajatovic
Overview
Explore the profile of Miljenko Valentin Panajatovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abegg V, Panajatovic M, Mancuso R, Allard J, Duthaler U, Odermatt A, et al.
Toxicol Lett
. 2024 Jan;
393:1-13.
PMID: 38219807
St. John's Wort preparations are used for the treatment of mild to moderate depression. They are usually well tolerated but can cause adverse reactions including liver toxicity in rare cases....
2.
Panajatovic M, Singh F, Krahenbuhl S, Bouitbir J
Biomedicines
. 2020 Sep;
8(9).
PMID: 32942550
Several studies showed an increased risk for diabetes with statin treatment. PGC-1α is an important regulator of muscle energy metabolism and mitochondrial biogenesis. Since statins impair skeletal muscle PGC-1α expression...
3.
Bouitbir J, Panajatovic M, Frechard T, Roos N, Krahenbuhl S
Front Pharmacol
. 2020 Aug;
11:1106.
PMID: 32792947
Tyrosine kinase inhibitors (TKIs) can cause skeletal muscle toxicity in patients, but the underlying mechanisms are mostly unclear. The goal of the current study was to better characterize the role...
4.
Panajatovic M, Singh F, Roos N, Duthaler U, Handschin C, Krahenbuhl S, et al.
Acta Physiol (Oxf)
. 2019 Oct;
228(4):e13402.
PMID: 31605661
Aim: Statins decrease cardiovascular complications, but can induce myopathy. Here, we explored the implication of PGC-1α in statin-associated myotoxicity. Methods: We treated PGC-1α knockout (KO), PGC-1α overexpression (OE) and wild-type...